European principles of inhibitor management in patients with haemophilia von Giangrande, P L F, Hermans, C, O'Mahony, B, de Kleijn, P, Bedford, M, Batorova, A, Blatný, J, Jansone, K

Volltext

Magneto-mechanical Design of an Electromagnetically Actuated Coaxial Magnet Coupling for Fault Protection von Akcay, Y., Tweedy, O.R., Giangrande, P., Galea, M.

Volltext

Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders von PEYVANDI, F., PALLA, R., MENEGATTI, M., SIBONI, S. M., HALIMEH, S., FAESER, B., PERGANTOU, H., PLATOKOUKI, H., GIANGRANDE, P., PEERLINCK, K., CELKAN, T., OZDEMIR, N., BIDLINGMAIER, C., INGERSLEV, J., GIANSILY‐BLAIZOT, M., SCHVED, J. F., GILMORE, R., GADISSEUR, A., BENEDIK‐DOLNIČAR, M., KITANOVSKI, L., MIKOVIC, D., MUSALLAM, K. M., ROSENDAAL, F. R.

Volltext

Guidelines for the management of acute joint bleeds and chronic synovitis in haemophilia: A United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO) guideline von Hanley, J, McKernan, A, Creagh, M D, Classey, S, McLaughlin, P, Goddard, N, Briggs, P J, Frostick, S, Giangrande, P, Wilde, J, Thachil, J, Chowdary, P

Volltext

European principles of inhibitor management in patients with haemophilia: implications of new treatment options von Hermans, C, Giangrande, P. L. F, O'Mahony, B, de Kleijn, P, Bedford, M, Batorova, A, Blatný, J, Jansone, K, Astermark, J, Crato, M, d'Oiron, R, Dougall, A, Fijnvandraat, K, Granhaug, S, Jiménez-Yuste, V, JokiÄ, M, Lobet, S, Nolan, B, Peyvandi, F, Ryan, A

Volltext

Haemophilia care in Europe - a survey of 35 countries von O'Mahony, B., Noone, D., Giangrande, P. L. F., Prihodova, L.

Volltext

Guidelines for the management of acute joint bleeds and chronic synovitis in haemophilia von Hanley, J., McKernan, A., Creagh, M. D., Classey, S., McLaughlin, P., Goddard, N., Briggs, P. J., Frostick, S., Giangrande, P., Wilde, J., Thachil, J., Chowdary, P.

Volltext

Porcine factor VIII von GIANGRANDE, P. L. F.

Volltext

Making economic evaluations more helpful for treatment choices in haemophilia von Drummond, M., Houwing, N., Slothuus, U., Giangrande, P.

Volltext

A role for Myc in facilitating transcription activation by E2F1 von Leung, J Y, Ehmann, G L, Giangrande, P H, Nevins, J R

Volltext

Kreuth IV: European consensus proposals for treatment of haemophilia with coagulation factor concentrates von Giangrande, P. L. F., Peyvandi, F., O'Mahony, B., Behr‐Gross, M.‐E., Hilger, A., Schramm, W., Mannucci, P. M.

Volltext

Haemophilia Care in Europe: the ESCHQoL study von Schramm, W., Gringeri, A., Ljung, R., Berger, K., Crispin, A., Bullinger, M., Giangrande, P. L. F., Von Mackensen, S., Mantovani, L. G., Nemes, L., Serban, M.

Volltext

Low‐factor consumption for major surgery in haemophilia B with long‐acting recombinant glycoPEGylated factor IX von Escobar, M. A., Tehranchi, R., Karim, F. A., Caliskan, U., Chowdary, P., Colberg, T., Giangrande, P., Giermasz, A., Mancuso, M. E., Serban, M., Tsay, W., Mahlangu, J. N.

Volltext

The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977–99 von Darby, S. C., Keeling, D. M., Spooner, R. J. D., Wan Kan, S., Giangrande, P. L. F., Collins, P. W., Hill, F. G. H., Hay, C. R. M.

Volltext

40K glycoPEGylated, recombinant FVIIa: 3‐month, double‐blind, randomized trial of safety, pharmacokinetics and preliminary efficacy in hemophilia patients with inhibitors von Ljung, R., Karim, F. A., Saxena, K., Suzuki, T., Arkhammar, P., Rosholm, A., Giangrande, P.

Volltext

Haemophilia care in Europe: a survey of 19 countries von O'MAHONY, B., NOONE, D., GIANGRANDE, P. L. F., PRIHODOVA, L.

Volltext

The history of blood transfusion von Giangrande, Paul L. F.

Volltext

Perioperative management of haemophilia B: A critical appraisal of the evidence and current practices von Neufeld, E. J., Solimeno, L., Quon, D., Walsh, C., Seremetis, S., Cooper, D., Iyer, N. N., Hoxer, C. S., Giangrande, P.

Volltext

Kreuth III: European consensus proposals for treatment of haemophilia with coagulation factor concentrates von Giangrande, P., Seitz, R., Behr-Gross, M. E., Berger, K., Hilger, A., Klein, H., Schramm, W., Mannucci, P. M.

Volltext

Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven®] in elective orthopaedic surgery in haemophilic patients with inhibitors von GIANGRANDE, P. L. F., WILDE, J. T., MADAN, B., LUDLAM, C. A., TUDDENHAM, E. G. D., GODDARD, N. J., DOLAN, G., INGERSLEV, J.

Volltext